Search Results 461-470 of 14937 for infliximab
Final days of 5X Challenge! 5X My Gift! The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology. 5X My Gift!
The purpose of this study is to assess outcomes, satisfaction and aesthetics of two different breast reconstruction techniques (Goldilocks alone, ...
Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...
Approximately 358 patients will be randomized in a 1:1 ratio to DCC-2618 150 mg once daily (QD) (continuous dosing for 6 week cycles) or sunitinib 50 mg QD (6 ...
Clinical trials are research studies that involve volunteer participants. These human studies help doctors better understand, diagnose, treat, and prevent ...
... infliximab, and plasma exchange. Currently enrolled in another interventional study utilizing systemic agents for the management of ICI-related toxicities ...
* Patients previously treated with immunosuppressive or other immunomodulatory agents such as but not limited to cyclophosphamide, rituximab, infliximab ...
Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.
Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...
Patients will be randomized to receive 8 mg/kg RoActemra/Actemra intravenously every 4 weeks or 50 mg etane rcept subcutaneously weekly. The anticipated time on ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.